Saturday 17 October 2026
Export HAO’s income statement to Excel — free account
Haoxi Health Technology Limited
HAO Communication Services Advertising Agencies
Haoxi Health Technology Limited’s revenue for fiscal 2026 (year ended June 2026) was $54.8 million, up 67.1% from fiscal 2025. Insiders bought in the last twelve months.
2.10
0.09
−4.11%
Follow HAO
| Jun '21 | Dec '21 | Jun '22 | Dec '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 3 | 4 | 3 |
Altman Z-Score |
— | — | — | — | — | 5.42 | 2.81 | 1.55 |
Altman Z″-Score (non-manufacturers) |
(25.56) | (25.56) | (25.56) | — | 3.57 | 8.56 | 9.17 | 5.28 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | 0.39 | 13.57 | 5,459.16 | (3.04) |
P/Operating CF |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | — | 0.00 | 2.77 | 1.11 | 0.61 |
EV/FCF |
0.00 | 0.00 | 0.00 | — | 0.00 | 2.60 | 1.09 | 0.60 |
Quick Ratio |
0.15 | 0.15 | 0.15 | 0.00 | 0.47 | 1.78 | 2.34 | 2.95 |
Current Ratio |
0.22 | 0.22 | 0.22 | 0.00 | 1.43 | 3.98 | 5.05 | 4.53 |
Net Debt/EBITDA |
(1.09) | (1.09) | 0.54 | (0.31) | (0.37) | (3.20) | 4.12 | 1.01 |
Debt/Assets |
0.00% | 0.00% | 80.92% | 3,235.06% | 17.04% | 7.32% | 8.87% | 7.47% |
Debt/Equity |
0.00 | 0.00 | (0.30) | 0.00 | 0.49 | 0.10 | 0.11 | 0.09 |
Asset Turnover |
0.00 | 29.75 | 29.75 | 0.00 | 12.63 | 4.86 | 1.77 | 2.54 |
Operating CF/Net income |
0.00 | 0.00 | (2.76) | 0.00 | (0.90) | (0.58) | (0.87) | 0.27 |
Capex/Depreciation |
— | — | (3.95) | — | (5.42) | (5.23) | (5.59) | 0.00 |
Interest Coverage |
26.89 | 26.89 | 26.88 | — | 57.22 | 41.68 | (43.48) | (184.43) |
| 0.00% | (15.90%) | (16.29%) | 0.00% | 1,924.21% | 20.12% | 27.06% | (54.13%) | |
| 0.00% | 45.05% | 45.05% | 352.21% | 43.37% | 12.94% | 20.90% | (44.18%) | |
ROIC |
0.00% | 0.00% | 0.00% | (202.75%) | 66.50% | 18.66% | (11.71%) | (70.74%) |
Return on Tangible Assets |
(15.74%) | (15.74%) | (15.74%) | 12,594.81% | 78.12% | 11.10% | 24.49% | (72.20%) |
Average Days of Receivables |
0.09 | 0.09 | 0.09 | 0.00 | 0.10 | 1.71 | 5.12 | 0.04 |
Research and Development Expense of Revenue |
0.63% | 0.63% | 0.63% | — | 0.21% | 0.16% | 0.24% | 0.19% |
Selling, General and Administrative Expense of Revenue |
1.72% | 1.72% | 1.72% | 0.00% | 2.86% | 1.96% | 8.68% | 15.84% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.18% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 40,392.25 | — | 70,573.00 | 97,039.60 | 36,449.22 | 2,219.79 |
Operating CF per Share |
— | — | (1,688.50) | — | (2,180.25) | (1,495.20) | (3,731.22) | (103.99) |
Capex per Share |
— | — | (21.75) | — | (113.75) | (110.80) | (2,311.11) | 0.00 |
Free Cash Flow per Share |
— | — | (1,710.25) | — | (2,294.00) | (1,606.00) | (6,042.33) | (103.99) |
Cash per Share |
0.00 | 0.00 | 733.75 | — | 3,008.00 | 13,311.40 | 9,576.11 | 442.64 |
Shareholders Equity per Share |
0.00 | 0.00 | (3,664.25) | — | 3,916.25 | 22,544.00 | 19,307.11 | 723.06 |
Interest Debt per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | (3,664.25) | — | 3,916.25 | 22,544.00 | 19,307.11 | 723.06 |
Free Cash Flow |
— | — | (0.68) | — | (0.92) | (0.80) | (5.44) | (2.57) |
Working Capital |
(1.56) | (1.56) | (1.56) | 0.01 | 1.10 | 11.51 | 15.72 | 13.10 |
Capital Expenditures |
— | — | (0.01) | — | (0.05) | (0.06) | (2.08) | — |
Net Current Asset Value |
(1.56) | (1.56) | (1.56) | (0.24) | 0.78 | 11.15 | 15.39 | 13.10 |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.06 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.23 | — | 0.06 | 0.08 | 3.41 | 3.74 |
Cash ROIC |
0.00% | 0.00% | 93.35% | 0.00% | (25.99%) | (4.21%) | (19.48%) | (8.45%) |
Accounts Receivable Turnover |
0.00 | 4,142.79 | 4,142.79 | 0.00 | 3,666.13 | 413.99 | 95.50 | 235.22 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — | 39.46 | 129.22 | 78.94 | 345.22 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 29.93 | — | 0.76 | 5.21 | 1.76 | 1.08 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.00 | 0.00 | 0.01 | 0.01 | 0.12 | 0.34 | 0.23 |
Average Payables |
— | — | — | — | 0.66 | 0.35 | 0.40 | 0.16 |
Average Assets |
— | 0.54 | 0.54 | 0.28 | 2.24 | 9.99 | 18.55 | 21.58 |
Average Common Equity |
— | (1.54) | (1.50) | — | 0.05 | 6.42 | 14.32 | 17.62 |
Columns are period end dates · fundamentals updated 8 Oct 2026